Skip to content
DAT Supply Log in
Amino acids · Sachets

L-Citrulline

L-Citrulline is a non-essential amino acid involved in the urea cycle and nitric oxide production. It is one of the most familiar and commercially understood amino acids for sports performance across EU and US markets. No EFSA-authorised health claims exist under Reg. (EU) 432/2012; brands typically position around general exercise support and nitric oxide pathways.

  • sports-recovery
  • energy-and-vitality
  • nitric-oxide-support
Build a formula with this ingredient
L-Citrulline

At a glance

Definition
L-Citrulline is a non-essential amino acid involved in the urea cycle and nitric oxide production. It is one of the most familiar and commercially understood amino acids for sports performance across EU and US markets. No EFSA-authorised health claims exist under Reg. (EU) 432/2012; brands typically position around general exercise support and nitric oxide pathways.
Common positionings
  • Sports performance
  • Endurance support
  • Nitric oxide support
  • Muscle recovery
  • Blood flow support
Format suitability
Reviewed for sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Available in
Positioning

What it is

L-Citrulline is a non-essential amino acid that plays a key role in the urea cycle, helping the body eliminate ammonia and recycle arginine. It is naturally found in watermelon and is produced industrially via fermentation for supplement use. Unlike arginine, L-Citrulline has superior oral bioavailability and is more effective at raising plasma arginine levels, making it a preferred precursor for nitric oxide synthesis.

Brands use L-Citrulline primarily in sports nutrition and performance products. Its ability to support nitric oxide production, improve blood flow, and reduce fatigue makes it a staple ingredient for endurance and recovery formulations. However, its effective dose range (3,000–10,000 mg) makes it impractical for gummy formats, and it is best delivered in sachet or powder formats.

Origin and history

L-Citrulline was first isolated from watermelon (Citrullus lanatus) in 1914 by Japanese researchers. Its name derives from the Latin word for watermelon, reflecting its natural abundance in the fruit. For decades, it remained a relatively obscure amino acid until research in the 1990s and 2000s revealed its role in the nitric oxide pathway and its superior bioavailability compared to arginine.

Today, L-Citrulline is produced industrially through bacterial fermentation using carbohydrates as feedstock. The fermentation process yields high-purity L-Citrulline that is suitable for food supplement applications. It is available as free-form L-Citrulline or as L-Citrulline DL-Malate, which combines citrulline with malic acid for potential additional energy benefits.

Scientific overview

L-Citrulline is a key intermediate in the urea cycle, where it helps convert ammonia into urea for excretion. More importantly for sports nutrition, it serves as a precursor to arginine, which is converted to nitric oxide via nitric oxide synthase. Nitric oxide is a vasodilator that improves blood flow, oxygen delivery, and nutrient transport to muscles during exercise. Unlike direct arginine supplementation, L-Citrulline bypasses first-pass metabolism in the liver and the intestinal arginase enzyme, resulting in more sustained and higher plasma arginine levels.

The bioavailability of L-Citrulline is excellent, with oral doses showing significant increases in plasma citrulline and arginine levels within 1–2 hours. The effective dose range for sports performance is typically 3,000–10,000 mg, with most studies using 6,000 mg as a standard dose. L-Citrulline DL-Malate is often used at similar doses and may offer additional benefits from malic acid in the ATP energy cycle.

From a manufacturing perspective, L-Citrulline is heat-stable and soluble in water, making it suitable for sachet and powder formats. However, its high effective dose makes it impractical for gummy formats, where payload constraints limit the amount of active per piece. The slightly bitter taste requires masking in ready-to-mix powders or sachets. Cost per mg is moderate, but the high dose means per-serving costs are significant.

Why brands use L-Citrulline

L-Citrulline is one of the most familiar and commercially understood amino acids for sports performance across EU and US markets. Brands use it to position products around endurance, recovery, and nitric oxide support. However, its effective dose of 3,000–10,000 mg per serving makes it impractical for gummy formats, where a single gummy typically delivers 50–200 mg of active. A 6,000 mg dose would require 30–120 gummies per serving, which is commercially unviable.

For brands committed to gummy formats, L-Citrulline can be included at lower, sub-effective doses as part of a broader amino acid blend or combined with other nitric oxide precursors like arginine and beetroot extract. However, the primary delivery format for L-Citrulline remains sachets and powders. DAT can advise on the best format for your target dose and market positioning.

Pack copy for L-Citrulline should avoid disease claims and unauthorised structure-function language. In the EU, no specific health claims are authorised under Reg. (EU) 432/2012. Brands should position around general wellness, sports performance, or nitric oxide support without making specific health claims. DAT reviews claim wording per project to ensure compliance with local regulations.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Impractical
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Medium

Forms available

  • L-Citrulline (free-form), L-Citrulline DL-Malate

Dosage reference

Effective doses for sports performance typically range from 3,000 mg to 10,000 mg per serving. These doses are impractical for gummy formats due to payload constraints. Sachet or powder formats are recommended. No EU NRV established.

Taste & sensory

Slightly bitter amino acid taste. Masking may be required in sachet formats.

Manufacturing notes

Gummy-optimized dosing; check payload constraints. For sachet formats, consider taste masking and solubility.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

EU-authorised health claims

EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.

Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.

L-Citrulline is a permitted amino acid for food supplements in the EU under Directive 2002/46/EC. No specific health claims are authorised under Reg. (EU) 432/2012. Brands should position around general wellness, sports performance, or nitric oxide support without making disease or structure-function claims in EU consumer-facing copy. DAT reviews claim wording per project.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. Gonzalez AM, Trexler ET·Nutrients·2020

  2. Suzuki T, Morita M, Kobayashi Y, Kamimura A·Journal of the International Society of Sports Nutrition·2016

  3. Pérez-Guisado J, Jakeman PM·Journal of Strength and Conditioning Research·2010

  4. Allerton TD, Proctor DN, Stephens JM, Dugas TR, Spielmann G, Irving BA·Nutrition Reviews·2018

  5. EFSA Panel on Nutrition, Novel Foods and Food Allergens·EFSA Journal·2021

Catalogue match

Product concepts featuring L-Citrulline

Private-label product concepts where L-Citrulline appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Pairs with Arginine (NO pathway), Beetroot (dietary nitrates), Beta-Alanine (endurance).

Care when combining with

NOT feasible in gummies at full dose (4-6g). Powder better. Better NO production profile than arginine.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with L-Citrulline on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with L-Citrulline.

Project handoff

Develop a formula featuring L-Citrulline

A ready white-label formula exists — open a product brief, or talk to our team to align the launch plan.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.